Emmanuel Buys1, Patrick Sips. 1. aAnesthesia Center for Critical Care Research, Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital bDivision of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Abstract
PURPOSE OF REVIEW: Nitric oxide (NO)-soluble guanylate cyclase (sGC)-dependent signaling mechanisms have a profound effect on the regulation of blood pressure (BP). In this review, we will discuss recent findings in the field that support the importance of sGC in the development of hypertension. RECENT FINDINGS: The importance of sGC in BP regulation was highlighted by studies using genetically modified animal models, chemical stimulators/activators and inhibitors of the NO/sGC signaling pathway, and genetic association studies in humans. Many studies further support the role of NO/sGC in vasodilation and vascular dysfunction, which is underscored by the early clinical success of synthetic sGC stimulators for the treatment of pulmonary hypertension. Recent work has uncovered more details about the structural basis of sGC activation, enabling the development of more potent and efficient modulators of sGC activity. Finally, the mechanisms involved in the modulation of sGC by signaling gases other than NO, as well as the influence of redox signaling on sGC, have been the subject of several interesting studies. SUMMARY: sGC is fast becoming an interesting therapeutic target for the treatment of vascular dysfunction and hypertension, with novel sGC stimulating/activating compounds as promising clinical treatment options.
PURPOSE OF REVIEW: Nitric oxide (NO)-soluble guanylate cyclase (sGC)-dependent signaling mechanisms have a profound effect on the regulation of blood pressure (BP). In this review, we will discuss recent findings in the field that support the importance of sGC in the development of hypertension. RECENT FINDINGS: The importance of sGC in BP regulation was highlighted by studies using genetically modified animal models, chemical stimulators/activators and inhibitors of the NO/sGC signaling pathway, and genetic association studies in humans. Many studies further support the role of NO/sGC in vasodilation and vascular dysfunction, which is underscored by the early clinical success of synthetic sGC stimulators for the treatment of pulmonary hypertension. Recent work has uncovered more details about the structural basis of sGC activation, enabling the development of more potent and efficient modulators of sGC activity. Finally, the mechanisms involved in the modulation of sGC by signaling gases other than NO, as well as the influence of redox signaling on sGC, have been the subject of several interesting studies. SUMMARY:sGC is fast becoming an interesting therapeutic target for the treatment of vascular dysfunction and hypertension, with novel sGC stimulating/activating compounds as promising clinical treatment options.
Authors: Hossein-Ardeschir Ghofrani; Andrea M D'Armini; Friedrich Grimminger; Marius M Hoeper; Pavel Jansa; Nick H Kim; Eckhard Mayer; Gerald Simonneau; Martin R Wilkins; Arno Fritsch; Dieter Neuser; Gerrit Weimann; Chen Wang Journal: N Engl J Med Date: 2013-07-25 Impact factor: 91.245
Authors: Hossein-Ardeschir Ghofrani; Nazzareno Galiè; Friedrich Grimminger; Ekkehard Grünig; Marc Humbert; Zhi-Cheng Jing; Anne M Keogh; David Langleben; Michael Ochan Kilama; Arno Fritsch; Dieter Neuser; Lewis J Rubin Journal: N Engl J Med Date: 2013-07-25 Impact factor: 91.245
Authors: Jennifer C Irvine; Nga Cao; Swati Gossain; Amy E Alexander; Jane E Love; Chengxue Qin; John D Horowitz; Barbara K Kemp-Harper; Rebecca H Ritchie Journal: Am J Physiol Heart Circ Physiol Date: 2013-05-31 Impact factor: 4.733
Authors: Asger Andersen; Jan M Nielsen; Sarah Holmboe; Mads D Vildbrad; Jens E Nielsen-Kudsk Journal: J Cardiovasc Pharmacol Date: 2013-08 Impact factor: 3.105
Authors: Nicola Wilck; Lajos Markó; András Balogh; Kristin Kräker; Florian Herse; Hendrik Bartolomaeus; István A Szijártó; Maik Gollasch; Nadine Reichhart; Olaf Strauss; Arnd Heuser; Damian Brockschnieder; Axel Kretschmer; Ralf Lesche; Florian Sohler; Johannes-Peter Stasch; Peter Sandner; Friedrich C Luft; Dominik N Müller; Ralf Dechend; Nadine Haase Journal: JCI Insight Date: 2018-02-22
Authors: Martin Braud; David A Magee; Stephen D E Park; Tad S Sonstegard; Sinead M Waters; David E MacHugh; Charles Spillane Journal: Front Genet Date: 2017-01-31 Impact factor: 4.599